Concepedia
4
Publications
92
Citations
H-Index
2015
Active since
Affiliations
Research Triangle Park Foundation(Current)
GlaxoSmithKline (United States)
GlaxoSmithKline (United Kingdom)
Quotient Clinical (United Kingdom)
Rennan Pan is an author at Research Triangle Park Foundation.
Publications per year
2015–2022
Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans
Gary D. Bowers, Amanda Culp, Melinda J. Reese et al. · Xenobiotica · 2015 · 52 citations
Effect of a High‐Fat Meal on the Pharmacokinetics of the HIV Integrase Inhibitor Cabotegravir
Parul Patel, Susan L. Ford, Yu Lou et al. · Clinical Pharmacology in Drug Development · 2018 · 18 citations · Full text
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
Debra Tompson, Mark Whitaker, Rennan Pan et al. · Pharmaceutical Research · 2021 · 11 citations · Full text
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology
Debra Tompson, Mark Whitaker, Rennan Pan et al. · Pharmaceutical Research · 2022 · 11 citations · Full text
Rows per page
1–4 of 4